Detalles de la búsqueda
1.
Seven-plus hours of daily sedentary time and the subsequent risk of breast cancer: Japan Multi-Institutional Collaborative Cohort Study.
Cancer Sci
; 115(2): 611-622, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38041484
2.
[A Case of Aortitis Caused by Pegfilgrastim Use during Neoadjuvant Chemotherapy for Treating Breast Cancer].
Gan To Kagaku Ryoho
; 49(5): 573-576, 2022 May.
Artículo
en Japonés
| MEDLINE | ID: mdl-35578937
3.
The effect of denosumab in breast cancer patients receiving adjuvant aromatase inhibitors: 36-month results.
J Bone Miner Metab
; 39(2): 224-229, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32889575
4.
[Experience of Fulvestrant for Hormone Receptor-Positive HER2-Negative Advanced and Metastatic Breast Cancer].
Gan To Kagaku Ryoho
; 45(6): 949-954, 2018 Jun.
Artículo
en Japonés
| MEDLINE | ID: mdl-30026420
6.
[Metastatic breast cancer with microangiopathic hemolytic anemia successfully treated by using eribulin].
Gan To Kagaku Ryoho
; 41(9): 1139-41, 2014 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-25248898
7.
Investigation of recurrence prediction ability of EndoPredict® using microarray data from fresh frozen tissues in ER-positive, HER2-negative breast cancer and indication expansion of EndoPredict® from microarray data from fresh-frozen to FFPE tissues.
Breast Cancer
; 2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38587783
8.
Multi-gene assay 95- and 155-gene classifiers for prognosis prediction and chemotherapy omission in lymphnode positive luminal-type breast cancer.
Cancer Treat Res Commun
; 36: 100711, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37245351
9.
Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib.
Anticancer Res
; 43(6): 2783-2789, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37247903
10.
The Impact of Being Underweight on the Prognosis of Older Patients With Early Breast Cancer.
Cancer Diagn Progn
; 3(6): 678-686, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37927809
11.
Detection of high-risk patients resistant to CDK4/6 inhibitors with hormone receptor-positive HER2-negative advanced and metastatic breast cancer in Japan (KBCSG-TR-1316).
Breast Cancer
; 30(6): 943-951, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37486454
12.
Myoid hamartoma of the breast that proved difficult to diagnose: a case report.
World J Surg Oncol
; 10: 12, 2012 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-22248347
13.
[Administration of nab-paclitaxel for 9 metastatic breast cancer patients].
Gan To Kagaku Ryoho
; 39(7): 1081-5, 2012 Jul.
Artículo
en Japonés
| MEDLINE | ID: mdl-22790043
14.
[A case of effective lapatinib/capecitabine therapy for HER2-positive breast cancer with multiple brain metastases].
Gan To Kagaku Ryoho
; 39(11): 1699-702, 2012 Nov.
Artículo
en Japonés
| MEDLINE | ID: mdl-23152022
15.
Is adjuvant chemotherapy necessary in older patients with breast cancer?
Breast Cancer
; 29(3): 498-506, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032302
16.
[A case of effective combination therapy with docetaxel, cyclophosphamide and trastuzumab as primary systemic therapy for locally advanced HER2-positive breast cancer].
Gan To Kagaku Ryoho
; 38(9): 1491-4, 2011 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-21918347
17.
Plasmalogen Deficiency and Overactive Fatty Acid Elongation Biomarkers in Serum of Breast Cancer Patients Pre- and Post-Surgery-New Insights on Diagnosis, Risk Assessment, and Disease Mechanisms.
Cancers (Basel)
; 13(16)2021 Aug 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34439324
18.
Fluorescence-based discrimination of breast cancer cells by direct exposure to 5-aminolevulinic acid.
Cancer Med
; 8(12): 5524-5533, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31385432
19.
Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer.
Breast Cancer
; 24(1): 63-68, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26754092
20.
Docetaxel, cyclophosphamide, and trastuzumab as neoadjuvant chemotherapy for HER2-positive primary breast cancer.
Breast Cancer
; 24(1): 92-97, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26874836